Therapy with conventional antiarrhythmic drugs for ventricular arrhythmias (Q40214486)

18 September 2017

1 reference

title

Therapy with conventional antiarrhythmic drugs for ventricular arrhythmias (English)

1 reference

18 September 2017

Nestico PF

1

1 reference

18 September 2017

DePace NL

series ordinal

2

1 reference

18 September 2017

Morganroth J

series ordinal

3

1 reference

18 September 2017

publication date

1 September 1984

1 reference

Medical Clinics of North America

18 September 2017

published in

1 reference

18 September 2017

volume

68

1 reference

18 September 2017

issue

5

1 reference

18 September 2017

page(s)

1295-1319

1 reference

Clinical electrophysiologic effects of tocainide

18 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31096-3

7 January 2021

Effect of lidocaine hydrochloride on membrane conductance in mammalian cardiac Purkinje fibers

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31096-3

7 January 2021

Treatment of ventricular fibrillation and other acute arrhythmias with bretylium tosylate

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31096-3

7 January 2021

Bretylium tosylate for suppression of induced ventricular fibrillation

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31096-3

7 January 2021

A prospective randomized trial of tocainide in patients following myocardial infarction

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31096-3

7 January 2021

Myocardial Depression with Disopyramide

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31096-3

7 January 2021

Electrophysiologic effects of the antiarrhythmic agent disopyramide phosphate

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31096-3

7 January 2021

Lidocaine disposition kinetics in monkey and man. II. Effects of hemorrhage and sympathomimetic drug administration

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31096-3

7 January 2021

Effectiveness of Bretylium Tosylate against Refractory Ventricular Arrhythmias

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31096-3

7 January 2021

The effect of bretylium tosylate on the electrophysiologic properties of ventricular muscle and purkinje fibers

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31096-3

7 January 2021

Effect of lidocaine on the electrophysiological properties of ventricular muscle and Purkinje fibers

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31096-3

7 January 2021

Comparative effects of lidocaine and procainamide on acutely impaired hemodynamics.

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31096-3

7 January 2021

Relation of ventricular premature beat suppression to serum quinidine concentraton determined by a new and specific assay

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31096-3

7 January 2021

Response of resistant ventricular tachycardia to bretylium. Relation to site of ectopic focus and location of myocardial disease.

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31096-3

7 January 2021

Plasma Propranolol Levels Associated with Suppression of Ventricular Ectopic Beats

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31096-3

7 January 2021

SOME CELLULAR AND METABOLIC CONSIDERATIONS RELATING TO THE ACTION OF QUINIDINE AS A PROTOTYPE ANTIARRHYTHMIC AGENT

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31096-3

7 January 2021

The effect of congestive heart failure on quinidine pharmacokinetics

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31096-3

7 January 2021

Interaction of Quinidine with Anticonvulsant Drugs

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31096-3

7 January 2021

Effects of propranolol on the transmembrane potentials of ventricular muscle and Purkinje fibers of the dog.

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31096-3

7 January 2021

Use of bretylium tosylate in the management of acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31096-3

7 January 2021

Lidocaine metabolism in normal and phenobarbital-pretreated dogs.

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31096-3

7 January 2021

Quinidine-digoxin interaction: Pharmacokinetics, underlying mechanism and clinical implications

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31096-3

7 January 2021

Prevalence of high (3S)-3-hydroxyquinidine/quinidine ratios in serum, and clearance of quinidine in cardiac patients with age

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31096-3

7 January 2021

Steady-state serum levels of quinidine and active metabolites in cardiac patients with varying degrees of renal function

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31096-3

7 January 2021

Cumulation of N-acetylprocainamide, an active metabolite of procainamide, in patients with impaired renal function

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31096-3

7 January 2021

Tocainide protein binding in normal volunteers and trauma patients

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31096-3

7 January 2021

Tocainide kinetics and metabolism: effects of phenobarbital and substrates of glucuronyl transferase

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31096-3

7 January 2021

Tocainide-induced ventricular fibrillation

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31096-3

7 January 2021

Disposition of propranolol. V. Drug accumulation and steady-state concentrations during chronic oral administration in man.

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31096-3

7 January 2021

Reduction of liver blood flow and propranolol metabolism by cimetidine

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31096-3

7 January 2021

Evaluation of propranolol and quinidine in the treatment of quinidine-resistant arrhythmias

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31096-3

7 January 2021

Quinidine Effects Due to Disopyramide

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31096-3

7 January 2021

Procaine amide against re-entrant ventricular arrhythmias. Lengthening R-V intervals of coupled ventricular premature depolarization as an insight into the mechanism of action of procaine amide.

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31096-3

7 January 2021

Efficacy, plasma concentrations and adverse effects of a new sustained release procainamide preparation

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31096-3

7 January 2021

Intermittent intravenous procaine amide to treat ventricular arrhythmias. Correlation of plasma concentration with effect on arrhythmia, electrocardiogram, and blood pressure

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31096-3

7 January 2021

Tocainide kinetics after intravenous and oral administration in healthy subjects and in patients with acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31096-3

7 January 2021

Large dose procainamide therapy for ventricular tachyarrhythmia

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31096-3

7 January 2021

THE ANTIARRHYTHMIC PROPERTIES OF LIDOCAINE AND PROCAINE AMIDE. CLINICAL AND PHYSIOLOGIC STUDIES OF THEIR CARDIOVASCULAR EFFECTS IN MAN.

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31096-3

7 January 2021

The comparative inotropic effects of six clinically used antiarrhythmic agents

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31096-3

7 January 2021

Protein binding and erythrocyte partitioning of disopyramide and its monodealkylated metabolite.

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31096-3

7 January 2021

The effect of quinidine and its metabolites on the electrocardiogram and systolic time intervals: concentration--effect relationships.

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31096-3

7 January 2021

Safety evaluation of tocainide in the American Emergency Use Program

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31096-3

7 January 2021

Human Electropharmacology of Tocainide, a lidocaine congener

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31096-3

7 January 2021

The current status of procaine amide in the management of cardiac arrhythmias

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31096-3

7 January 2021

Quinidine Elimination in Patients with Congestive Heart Failure or Poor Renal Function

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31096-3

7 January 2021

Acetylprocainamide Therapy in Patients with Previous Procainamide-Induced Lupus Syndrome

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31096-3

7 January 2021

Quinidine-induced hypoprothrombinemic hemorrhage in patients on chronic warfarin therapy

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31096-3

7 January 2021

Pharmacokinetic of procainamide in man

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31096-3

7 January 2021

Drug therapy: bretylium

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31096-3

7 January 2021

Procainamide Dosage Schedules, Plasma Concentrations, and Clinical Effects

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31096-3

7 January 2021

Antiarrhythmic Prophylaxis with Procainamide in Acute Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31096-3

7 January 2021

Long-term use of procaine amide following acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31096-3

7 January 2021

Hypoglycaemia precipitated by propranolol

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31096-3

7 January 2021

Effects of disopyramide on systemic and coronary hemodynamics and myocardial metabolism in patients with coronary artery disease: comparison with lidocaine

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31096-3

7 January 2021

The effectiveness of antiarrhythmic agents on early-cycle premature ventricular complexes

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31096-3

7 January 2021

Sudden death in arteriosclerotic heart disease; the case for preventive medicine.

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31096-3

7 January 2021

Sudden death--definition and epidemiologic considerations

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31096-3

7 January 2021

Epidemiology of Sudden Death

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31096-3

7 January 2021

Disposition of bretylium in man and rat. A sensitive chemical method for its estimation in plasma and urine

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31096-3

7 January 2021

Effect of loading dose of procaine amide on left ventricular performance in man.

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31096-3

7 January 2021

ORAL DISOPYRAMIDE IN PROPHYLAXIS OF ARRHYTHMIAS FOLLOWING MYOCARDIAL INFARCTION

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31096-3

7 January 2021

Haemodynamic effects of intravenous disopyramide in heart failure

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31096-3

7 January 2021

Kinetics of the oral antiarrhythmie lidocaine congener, tocainide

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31096-3

7 January 2021

Cardiac depression by intravenous disopyramide in patients with left ventricular dysfunction.

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31096-3

7 January 2021

Anti-arrhythmic Action of Bretylium

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31096-3

7 January 2021

Approaches to sudden death from coronary heart disease

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31096-3

7 January 2021

Prevention of Recurrent Ventricular Tachycardia with Oral Bretylium Tosylate

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31096-3

7 January 2021

Open clinical studies at a referral center: chronic maintenance tocainide therapy in patients with recurrent sustained ventricular tachycardia refractory to conventional antiarrhythmic agents

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31096-3

7 January 2021

Intravenous propranolol administration: a method for rapidly achieving and sustaining desired plasma levels

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31096-3

7 January 2021

Atypical ventricular tachycardia as a manifestation of disopyramide toxicity

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31096-3

7 January 2021

Electrophysiologic properties of a new antiarrhythmic drug—Tocainide

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31096-3

7 January 2021

Effects of quinidine on serum digoxin concentration: a prospective study

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31096-3

7 January 2021

Relationship between plasma levels of procainamide, suppression of premature ventricular complexes and prevention of recurrent ventricular tachycardia

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31096-3

7 January 2021

Haemodynamic effects of disopyramide in patients after open-heart surgery

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31096-3

7 January 2021

Lidocaine and its active metabolites

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31096-3

7 January 2021

Disopyramide-induced ventricular fibrillation

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31096-3

7 January 2021

Clinical pharmacology of propranolol

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31096-3

7 January 2021

Hemodynamic and antiarrhythmic effects of tocainide in patients with acute myocardial infarction.

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31096-3

7 January 2021

Short- and long-term therapeutic efficacy of quinidine sulfate for the treatment of chronic ventricular arrhythmias

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31096-3

7 January 2021

Tocainide-associated interstitial pneumonitis

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31096-3

7 January 2021

Tocainide for refractory symptomatic ventricular arrhythmias

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31096-3

7 January 2021

Congestive heart failure caused by oral disopyramide

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31096-3

7 January 2021

Antiarrhythmic efficacy, pharmacokinetics and safety of N-acetylprocainamide in human subjects: Comparison with procainamide

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31096-3

7 January 2021

Tocainide therapy for refractory ventricular arrhythmias

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31096-3

7 January 2021

Evaluation of bretylium tosylate for the treatment of premature ventricular contractions

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31096-3

7 January 2021

On the kinetics and dynamics of tocainide and its metabolites

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31096-3

7 January 2021

Clinical Pharmacokinetics of Propranolol

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31096-3

7 January 2021

Efficacy of a new oral agent (tocainide) in the acute treatment of refractory ventricular arrhythmias

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31096-3

7 January 2021

Chemical ventricular defibrillation of the human heart with bretylium tosylate

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31096-3

7 January 2021

A COMPARISON OF THE ANTIFIBRILLATORY ACTIONS AND EFFECTS ON INTRACELLULAR CARDIAC POTENTIALS OF PRONETHALOL, DISOPYRAMIDE AND QUINIDINE.

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31096-3

7 January 2021

QUINIDINE SYNCOPE. PAROXYSMAL VENTRICULAR FIBRILLATION OCCURRING DURING TREATMENT OF CHRONIC ATRIAL ARRHYTHMIAS.

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31096-3

7 January 2021

Plasma propranolol levels in adults With observations in four children

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31096-3

7 January 2021

Effect of Altering Potassium Concentration on the Action of Lidocaine and Diphenylhydantoin on Rabbit Atrial and Ventricular Muscle

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31096-3

7 January 2021

The present status of therapy of the cardiac arrhythmias with quinidine

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31096-3

7 January 2021

Value and hazards of intravenous procaine amide ("pronestyl") therapy.

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31096-3

7 January 2021

Remission of Procainamide-Induced Lupus Erythematosus with N-Acetylprocainamide Therapy

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31096-3

7 January 2021

Interrelationships of Hepatic Blood Flow, Cardiac Output, and Blood Levels of Lidocaine in Man

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31096-3

7 January 2021

Bretylium tosylate in treatment of refractory ventricular arrhythmias complicating myocardial infarction

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31096-3

7 January 2021

Hemodynamic effects of disopyramide at rest and during exercise in normal subjects

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31096-3

7 January 2021

Efficacy of Disopyramide Phosphate in the Treatment of Refractory Ventricular Tachycardia

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31096-3

7 January 2021

Propranolol glucuronide cumulation during long-term propranolol therapy: a proposed storage mechanism for propranolol

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31096-3

7 January 2021

Adverse hemodynamic effects of intravenous disopyramide compared with quinidine in conscious dogs

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31096-3

7 January 2021

The hemodynamic effects of intravenous tocainide in patients with heart disease

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31096-3

7 January 2021

Antiarrhythmic drug effect assessed from ventricular arrhythmia reduction in the ambulatory electrocardiogram and treadmill test: comparison of propranolol, procainamide and quinidine

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31096-3

7 January 2021

Clinical efficacy and pharmacokinetics of a new orally effective antiarrhythmic, tocainide.

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31096-3

7 January 2021

Long-term tocainide therapy for ventricular arrhythmias

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31096-3

7 January 2021

Effect of acetylator phenotype on the rate at which procainamide induces antinuclear antibodies and the lupus syndrome

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31096-3

7 January 2021

Multiple bolus technique for lidocaine administration during the first hours of an acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31096-3

7 January 2021

Comprehensive treatment plan for the prevention of primary ventricular fibrillation in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31096-3

7 January 2021

Multiple bolus technique for lidocaine administration in acute ischemic heart disease. II. Treatment of refractory ventricular arrhythmias and the pharmacokinetic significance of severe left ventricular failure

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31096-3

7 January 2021

Treatment of ventricular arrhythmias with oral tocainide

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)31096-3

7 January 2021

10.1016/S0025-7125(16)31096-3

Identifiers

DOI

0 references

1 reference